Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Posner

Showing results (181-190 of 247) with videos related to

Pageof 25
Sort By:
Head & Neck|November 29, 2015
Human papillomavirus and induction chemotherapy versus concurrent chemoradiotherapy in locally advanced oropharyngeal cancer: The Dana Farber ExperienceJochen H Lorch, Glenn J Hanna, Marshall R Posner, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1985
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neckM R Posner, R R Weichselbaum, T J Fitzgerald, et al.
Contemporary Clinical Trials|March 13, 2012
Acupuncture for dysphagia after chemoradiation in head and neck cancer: rationale and design of a randomized, sham-controlled trialWeidong Lu, Peter M Wayne, Roger B Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Docetaxel: an active drug for squamous cell carcinoma of the head and neckA I Dreyfuss, J R Clark, C M Norris, et al.
Cancer Research|October 3, 2014
TGFβ receptor 1: an immune susceptibility gene in HPV-associated cancerChaya Levovitz, Dan Chen, Emma Ivansson, et al.
Journal of Personalized Medicine|July 29, 2023
The First Exploratory Personalized Medicine Approach to Improve Bariatric Surgery Outcomes Utilizing Psychosocial and Genetic Risk Assessments: Encouraging Clinical ResearchPanayotis K Thanos, Colin Hanna, Abrianna Mihalkovic, et al.
International Journal of Cancer|February 23, 2007
Human papillomavirus 16 and head and neck squamous cell carcinomaC Sloane Furniss, Michael D McClean, Judith F Smith, et al.
Frontiers in Oncology|April 25, 2022
Quality of Life Analysis of HPV-Positive Oropharyngeal Cancer Patients in a Randomized Trial of Reduced-Dose Versus Standard Chemoradiotherapy: 5-Year Follow-UpMai Takahashi, Michael Hwang, Krysztof Misiukiewicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neckT J Ervin, J R Clark, R R Weichselbaum, et al.
Cancer|October 20, 2011
Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trialYin Wu, Marshall R Posner, Lisa M Schumaker, et al.
Pageof 25

Showing results (181-190 of 247) with videos related to

Sort By:
Pageof 25
Head & Neck|November 29, 2015
Human papillomavirus and induction chemotherapy versus concurrent chemoradiotherapy in locally advanced oropharyngeal cancer: The Dana Farber ExperienceJochen H Lorch, Glenn J Hanna, Marshall R Posner, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1985
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neckM R Posner, R R Weichselbaum, T J Fitzgerald, et al.
Contemporary Clinical Trials|March 13, 2012
Acupuncture for dysphagia after chemoradiation in head and neck cancer: rationale and design of a randomized, sham-controlled trialWeidong Lu, Peter M Wayne, Roger B Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Docetaxel: an active drug for squamous cell carcinoma of the head and neckA I Dreyfuss, J R Clark, C M Norris, et al.
Cancer Research|October 3, 2014
TGFβ receptor 1: an immune susceptibility gene in HPV-associated cancerChaya Levovitz, Dan Chen, Emma Ivansson, et al.
Journal of Personalized Medicine|July 29, 2023
The First Exploratory Personalized Medicine Approach to Improve Bariatric Surgery Outcomes Utilizing Psychosocial and Genetic Risk Assessments: Encouraging Clinical ResearchPanayotis K Thanos, Colin Hanna, Abrianna Mihalkovic, et al.
International Journal of Cancer|February 23, 2007
Human papillomavirus 16 and head and neck squamous cell carcinomaC Sloane Furniss, Michael D McClean, Judith F Smith, et al.
Frontiers in Oncology|April 25, 2022
Quality of Life Analysis of HPV-Positive Oropharyngeal Cancer Patients in a Randomized Trial of Reduced-Dose Versus Standard Chemoradiotherapy: 5-Year Follow-UpMai Takahashi, Michael Hwang, Krysztof Misiukiewicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neckT J Ervin, J R Clark, R R Weichselbaum, et al.
Cancer|October 20, 2011
Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trialYin Wu, Marshall R Posner, Lisa M Schumaker, et al.
Pageof 25